TNF and viral infectious disease: This study also identified six additional patients on TNF-alpha inhibitors who had received either the yellow fever or oral typhoid vaccine (i.e., live-attenuated vaccines) and one patient on ustekinumab (IL12/23 inhibitor) who had received the yellow fever vaccine.